Participants - All

Sustainability and circular economy consultant at ACCIÓ (Catalan Agency for Business Competitiveness), and the Enterprise Europe Network (EEN).

Eureka National Project Coordinator in Spain

At MedTech BCN we simplify drug development with ready-to-use in vitro kits and a unique Shipping Medium that allows room-temperature transport of living cells.

AI‑engineered enzyme SD1253 lowers gut succinate to reduce inflammation, offering a first‑in‑class, disease‑modifying oral therapy for IBD.

Executive and C-Suite Profile. Science, R&D and Innovation Manager.

Eureka Project officer at CDTI supporting Spanish companies in internationalization and advising on Eureka Programs.

My company's and personal primary focus is education and knowledge dissemination. We partner with companies and organizations with our edtech platform.

Expert in global strategy and AI-driven efficiency. Leading SME expansion to Middle East markets with a focus on operational excellence and R&D application.

Engineer & entrepreneur specialized in R&D strategy. Co-founder of Deducible.es and Innovating.works, building AI tools to connect companies through innovation.

Co-Founder & Head of Innovation at ingubu.io, turning emerging technologies into scalable products and business value.

I support collaborators in receiving funds through all EU R&D collaborative programmes through project management, stakeholder collaboration, and dissemination.

Sustainable, surface and coating advanced materials looking for collaborations addressing topics such as: green-H2, air/water decontamination, noise-free.

EpiDisease SL, a biotechnology company founded in 2014, develops in vitro tools that allow data-based clinical decision making for complex human conditions based on epigenetics and genetics technologies.

We are an engineering services company for: Heating Ventilation Air Conditioning and Fire Risk with people evacuation Analysis and others.

I am a specialist in international research and innovation management. I am the CEO of Cliclab , a societal innovation company co-created in 2019. Change maker

I am Ana Bouchet, co-founder of Lifesome Therapeutics. I am an international expert in nanoparticle formulation, lipid biophysics and encapsulation processes. At Lifesome, I manage the production of the first antitumoral lipid nanoparticle in the market.

PhD neuroscientist with 20+ years across academia and industry. Since 2020, focused on translating science into value by supporting drug development, leading cross-functional teams, and advancing innovative therapies with strong patient and market impact.

I lead DIVERSA, turning advanced delivery science into clinical nanomedicines through patented sphingolipid nanotechnology and strong translational expertise. We help advance high‑value programs by overcoming delivery bottlenecks.

Oniria Therapeutics is a biopharmaceutical company in the field of precision oncology and focused on cancer persistence.